Central Lab Services Market worth US$8.18 billion by 2030with 6.5% CAGR | MarketsandMarkets
The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...
Arbor Biotechnologies Announces $73.9 Million Series C Financing to Advance Novel Gene Editing Therapeutics
Series C led by ARCH Venture Partners and TCGX with significant participation from existing and new investorsFinancing extends Arbor’s cash ...
FIRST EVER PATIENT DOSED WITH ALPIBECTIR-ETHIONAMIDE IN COMBINATION WITH FIRST-LINE TB DRUGS IN A 14-DAY PHASE 2 CLINICAL TRIAL
Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...
Scientists discover two common herbs that could be key to treating Alzheimer's
Scientists in California have developed a new chemical compound derived from rosemary and sage plants, which has already shown encouraging results in mice with Alzheimer's. The compound, carnosic acid ...
Two common herbs could be game-changing in treating Alzheimer's, research shows
In a new study, researchers have found that a new chemical compound derived from the herbs could help to combat Alzheimer's disease and provide a new approach to treating the condition in the future ...